Agilent Technologies beat Wall Street estimates for second-quarter profit and revenue on Wednesday, helped by strong demand for its tools and equipment used in drug development, sending its shares up ...

The use of GenAI is poised to expand throughout the supply chain landscape amid an increasingly complex and tumultuous global ...